Six Weeks of a NS5A Inhibitor (GS-5885), Protease Inhibitor (GS-9451) plus Peginterferon/Ribavirin (PR) Achieves High SVR4 Rates in Genotype 1 IL28B CC Treatment Naive HCV Patients: Interim Results of a Prospective, Randomized Trial

Alexander J Thompson, Mitchell L Shiffman, Lorenzo Rossaro, Reem Ghalib, Steven-Huy B Han, Kimberly L Beavers, Stephen Pianko, Jacob George, Lin He, Xiaoru Wu, Nikki Flores, Phil S Pang, Stephen J Rossi, John G McHutchison, Samuel S Lee, Andrew J Muir